Larvol Delta - Blade-Therapeutics-Announces-FDA-Orphan-Drug-Designation-Granted-to-Cudetaxestat-for-Treatment-of-Systemic-Sclerosis

cudetaxestat (BLD 0409) - Blade Therap

https://www.businesswire.com/news/home/20211014005220/en/Blade-Therapeutics-Announces-FDA-Orphan-Drug-Designation-Granted-to-Cudetaxestat-for-Treatment-of-Systemic-Sclerosis

Oct 14, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next